The Type A and Type B pilot civil society organisation (CSO) support programmes focused on supporting stronger engagement of CSOs at the country level, including in immunisation service delivery.
In 2006, two funding windows were approved as pilot programmes for civil society support, with a total budget of US$ 29.2 million:
- Type A support was designed to strengthen the coordination and representation of civil society organisations (CSO) through the provision of lump-sum grants;
- Type B support, intended for 10 countries, was aimed at including CSOs in the implementation of Gavi health systems strengthening (HSS) proposals or comprehensive multi-year plans (cMYPs).
The pilot countries for Type B support included Afghanistan, Bolivia, Burundi, the Democratic Republic of Congo, Ethiopia, Georgia, Ghana, Indonesia, Mozambique, and Pakistan. Although initially introduced for the period 2007–2009, the Gavi Board subsequently extended support further.
By 2012, over US$ 21 million had been disbursed to encourage stronger involvement of CSOs in the implementation of national programmes and in health system strengthening. Subsequently, in 2012, through the independent review committee process a further US$ 7.4 million was allocated to pilot countries already receiving Type B support. These extensions are intended to support the continuation of CSO activities, until a country initiates an application to the Health Systems Funding Platform (HSFP).
Evaluation of Type A and Type B pilot programmes
An independent evaluation of the Type A and Type B pilot programmes was completed in early 2012. The main findings suggested that Gavi support to CSOs remains important for the achievement of countries’ immunisation goals, particularly in those instances where CSOs play a significant role in delivering immunisation services. The report also highlighted the scope for improvements in programme design and implementation.
In response, Gavi has made important changes to its CSO programmatic support. Gavi is now transitioning to an approach where CSOs will receive support through a country’s Health Systems Funding Platform application. See Gavi’s management response to the independent evaluation.